Jupiter Research Capital (Asia) Ltd’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,918
Closed -$1.45M – 705
2026
Q2
$1.45M Buy
+10,918
New +$984K 0.16% 150
2026
Q1
– Sell
-5,207
Closed -$393K – 759
2025
Q4
$393K Buy
+5,207
New +$328K 0.08% 337

Other funds holding APGE

Jupiter Research Capital (Asia) Ltd's APGE Position: Q3 2026 in Review

Jupiter Research Capital (Asia) Ltd sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 10,918 shares — an estimated $1.45M sold.

Jupiter Research Capital (Asia) Ltd first reported a position in APGE in Q4 2025 and held it in 2 quarters. The position peaked at $1.45M in Q2 2026. 3 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

  • Jupiter Research Capital (Asia) Ltd reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Jupiter Research Capital (Asia) Ltd sold 10,918 Apogee Therapeutics shares in Q3 2026, an estimated $1.45M.
  • Jupiter Research Capital (Asia) Ltd first reported a position in Apogee Therapeutics in Q4 2025 and held it in 2 quarters.
  • Jupiter Research Capital (Asia) Ltd's Apogee Therapeutics position peaked at $1.45M in Q2 2026.
  • 3 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.